Tech and Healthcare Lead SP 500 Higher Financials Lag Berkshire Hathaways Stock Sales Signal Shift in Investment Strategy Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales 83YearOld Widow Confronts Credit Void After Husbands Death A Legacy of Financial Dependence Oil Prices Spike Over 2 as IranUS Air Strikes Rattle Markets Crypto Volatility Surges SafeHaven Currencies Gain as DeepSeek AI Disruption Sparks RiskOff Mood SLI Q1 2026 Earnings Narrower Loss Beats Estimates as Lithium Developer Advances Projects SEZL Q1 2026 Earnings EPS Beats Estimates by 1658 as Stock Edges Lower Geopark Ltd Q1 2026 Earnings EPS of 036 Highlights Profitability Amid Limited Data Trane Technologies Q1 2026 Earnings EPS Beat Drives Modest Share Gains Amid Steady Operational Execution WASH Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment CCAP Q1 2026 Earnings Narrow EPS Miss Highlights Steady Portfolio Returns Nextdoor Holdings NXDR Gains 637 as Shares Test Key Resistance at 228 Newton Golf NWTG Edges Lower 111 as Stock Tests Support at 085 Dolby Laboratories DLB Advances 336 Testing Resistance as Bullish Momentum Builds Smith Wesson SWBI Edges Higher as Shares Rebound Off Key Support Western Asset Bond Fund WEA Edges Higher as FixedIncome Investors Assess Rate Outlook Market Update Zimmer Biomet AnheuserBusch InBev and Viatris See Mixed Trading Activity SURG Q4 2025 Earnings Massive EPS Miss Surprises Market Hydrofarm HYFM Tests Sub1 Threshold as Bullish Momentum Builds CJ ENM Hosts Inaugural KEntertainment Summit Industry Giants Discuss KPop Business Strategies Beyond Oil Ltd Enters Revenue Execution Phase as US Foodservice Adoption Accelerates CTAS Q1 2026 Earnings EPS Slightly Misses Estimates Despite Positive Stock Reaction LRCX Q1 2026 Earnings EPS Beat Drives 347 Stock Gain Amid Strong Operational Execution Nvidias 745 Billion Profit and 102 Billion Buyback Fail to Lift Shares Stock Dips 13 in Extended Trading Drakes Iceman Rollout Strategy A Case Study in Sustained Marketing Momentum Vivani Medical Q1 2026 Earnings Slight EPS Beat Fails to Stem Stock Decline as PreRevenue Biotech Navigates Development Pipeline